Market Trends Takeda Pharmaceutical Non-GAAP EPS of ¥443.00, revenue of ¥3528.2B; raises FY outlookBy admin8996erT0allJanuary 30, 2025 jetcityimage/iStock Editorial via Getty Images Takeda Pharmaceutical (NYSE:TAK) has upgraded its full year outlook for growth, reflecting strong year-to-date product…
Market Trends Teva Pharmaceutical shares surged for seven straight sessions (NYSE:TEVA)By admin8996erT0allDecember 24, 2024 Teva Pharmaceutical (NYSE:TEVA) shares rose for seven straight sessions, as the stock closed about 1% higher at $22.42 on Tuesday.…
